<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40297">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02043223</url>
  </required_header>
  <id_info>
    <org_study_id>PR-13060</org_study_id>
    <nct_id>NCT02043223</nct_id>
  </id_info>
  <brief_title>Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit</brief_title>
  <official_title>Stopping Postpartum Vitamin A Supplementation: Are we Missing Concealed Benefit?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Centre for Diarrhoeal Disease Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peter Bergman, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska University Hospital, Huddinge, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>International Centre for Diarrhoeal Disease Research, Bangladesh</source>
  <oversight_info>
    <authority>Bangladesh: Ethical Review Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of post-partum maternal vitamin A
      supplementation on breast milk bioactive compounds and immune status, growth and morbidity
      of children in the first four months of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effect will be assessed by the milk and blood.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Breast milk TGF-beta</measure>
    <time_frame>Four months</time_frame>
    <safety_issue>No</safety_issue>
    <description>At three time points-
&lt; 3-day postpartum (before supplementation)
7 wk postpartum (1wk after 2nd dose of supplementation)
15 wk postpartum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breast milk secretory IgA (sIgA)</measure>
    <time_frame>Four months</time_frame>
    <safety_issue>No</safety_issue>
    <description>At three time points-
&lt; 3-day postpartum (before supplementation)
7 wk postpartum (1wk after 2nd dose of supplementation)
15 wk postpartum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infant T helper cell immune responses</measure>
    <time_frame>Four months</time_frame>
    <safety_issue>No</safety_issue>
    <description>PHA stimulated whole blood IL-10, IL-13, IFN-gamma and IL-17 responses at two time points-
7 wk of age (1wk after 2nd dose of maternal supplementation , as well as, 1wk after first doses of pentavalent vaccination)
15 wk of age (1wk after three doses of pentavalent vaccination)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant innate immune responses</measure>
    <time_frame>Four months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Tall like receptor (TLR)-4 and TLR9 agonist stimulated whole blood TNF-alpha and IL-10 and IFN-alpha responses at two time points-
7 wk of age (1wk after 2nd dose of maternal supplementation , as well as, 1wk after first doses of pentavalent vaccination)
15 wk of age (1wk after three doses of pentavalent vaccination)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Infant vitamin A status</measure>
    <time_frame>Four months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Infant plasma vitamin A status at 7 wk and 15 wk of age</description>
  </other_outcome>
  <other_outcome>
    <measure>Infant growth</measure>
    <time_frame>Four months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Infant Weight-for-Age z-score (WAZ) at 7 wk and 15 wk of age</description>
  </other_outcome>
  <other_outcome>
    <measure>Infant morbidity</measure>
    <time_frame>Four months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Infant morbidity status up to four months of age</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Vitamin A Deficiency</condition>
  <arm_group>
    <arm_group_label>Early postpartum vitamin A suppl.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose 200,000 IU vitamin A supplementation at &lt;3-day and placebo supplementation at 6-wk postpartum.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late postpartum vitamin A suppl.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo supplementation at &lt;3-day and single dose 200,000 IU vitamin A supplementation at 6-wk postpartum.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early &amp; late postpartum vitamin A suppl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200,000 IU vitamin A supplementation, both at &lt;3-day and 6-wk postpartum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No postpartum vitamin A suppl.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo supplementation, both at &lt;3-day and 6-wk postpartum.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin A (&lt;3-day postpartum)</intervention_name>
    <description>Single dose 200,000 IU vitamin A supplementation at &lt;3-day and placebo supplementation at 6-wk postpartum.</description>
    <arm_group_label>Early postpartum vitamin A suppl.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin A (6 wk postpartum)</intervention_name>
    <description>Placebo supplementation at &lt;3-day and single dose 200,000 IU vitamin A supplementation at 6-wk postpartum.</description>
    <arm_group_label>Late postpartum vitamin A suppl.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin A (&lt;3-day and 6 wk postpartum)</intervention_name>
    <description>200,000 IU vitamin A supplementation, both at &lt;3-day and 6-wk postpartum</description>
    <arm_group_label>Early &amp; late postpartum vitamin A suppl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo supplementation, both at &lt;3-day and 6-wk postpartum.</description>
    <arm_group_label>No postpartum vitamin A suppl.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women  &gt;-18 years of age with low-risk obstetric

        Exclusion Criteria:

          -  Pregnant women expecting a multiple birth

          -  Take vitamin A supplements during postpartum apart from study intervention

          -  Premature birth

          -  Newborn babies with birth defects and / or other serious diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>32 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shaikh M Ahmad, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Centre for Diarrhoeal Disease Research, Bangladesh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shaikh M Ahmad, Ph.D</last_name>
    <phone>+88029827001-10</phone>
    <phone_ext>3469</phone_ext>
    <email>smeahmad@icddrb.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raqib Rubhana, Ph.D</last_name>
    <phone>+88029827001-10</phone>
    <phone_ext>2404</phone_ext>
    <email>rubhana@icddrb.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>International Centre for Diarrhoeal Disease Research, Bangladesh</name>
      <address>
        <city>Dhaka</city>
        <zip>1212</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaikh M Ahmad, Ph.D</last_name>
      <phone>+88029827001-10</phone>
      <phone_ext>3469</phone_ext>
      <email>smeahmad@icddrb.org</email>
    </contact>
    <contact_backup>
      <last_name>Raqib Rubhana, Ph.D</last_name>
      <phone>+88029827001-10</phone>
      <phone_ext>2404</phone_ext>
      <email>rubhana@icddrb.org</email>
    </contact_backup>
    <investigator>
      <last_name>Shaikh M Ahmad, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>January 19, 2014</lastchanged_date>
  <firstreceived_date>December 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin A</keyword>
  <keyword>Breast milk</keyword>
  <keyword>Postpartum vitamin A supplementation</keyword>
  <keyword>Infant vaccine response</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin A Deficiency</mesh_term>
    <mesh_term>Night Blindness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
